Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Adenoma
Reports on adenoma findings from Harvard University provide new insights
April 13th, 2008
According to a study from the United States, "Radiation therapy is a potentially curative treatment for corticotroph adenomas refractory to surgery. Protons have an advantage over photons(x-rays) by depositing energy at the target with no exit dose, providing a lower dose to adjacent normal tissues." "Until recently, proton stereotactic radiotherapy (PSR) was available at only two U.S. centers; use will increase as proton facilities are under development. Our objective was to evaluate the efficacy and safety of PSR for persistent Cushing's disease (CD) and Nelson's syndrome (NS). This was a retrospective review of 38 patients (33 with CD and five with NS) treated...
Source: Pharma Investments, Ventures & Law Weekly (2008-04-13)
|
